Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
Charlie Dalin kept his illness a secret, treating himself with immunotherapy pills on a 64-day journey around the world. What ...
News-Medical.Net on MSN
Ultrasound-responsive nanocatchers enable precise in-situ tumor antigen capture
Professor Zhaohui Tang and Associate Professor Zhilin Liu from the team of Professor Xuesi Chen at the Changchun Institute of ...
Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...
Alison McCrary received a life-changing makeover from the Fab Five on a Season 8 episode of the Netflix reality series back ...
The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
Morning Overview on MSN
Why cancer returns years later, and how we can stop it
Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...
IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of fighting cancer.
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...
Tumor immunotherapy has rapidly emerged as a cornerstone in oncology, revolutionizing the treatment landscape for patients with advanced malignancies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results